Now, some studies suggest HDAC inhibitors may increase an epithelial-to-mesenchymal (EMT) phenotype transition in PCa treatment (Kong et al., 2012) while others suggest a change in the mesenchymal-to-epithelial transition (MET) phenotype (Wang et al., 2015). Here, HDAC9 is linked to posterior cortical atrophy.